Capgemini SE CGEMY · OTC
$27.48 +1.14% (+$0.31)
Summary
56 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It has raised its dividend 5 years in a row and pays out only 39% of profit.
- Analysts expect revenue to grow by 12% this fiscal year.
What to watch
- Revenue fell by 0.6% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.4 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 6.4% a year over 5 years. Over the last 3 years it fell by 0.6% a year. For the next fiscal year analysts expect revenue to grow by 12%. Earnings per share fell by 0.2% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, safe- Yield
- 2.95%
- Paid out of profit
- 39%
- Raised in a row
- 5 years
You receive $0.80 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 1
- Hold 2
- Sell 0
No analyst has published a price target.
33% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.